Literature DB >> 15960995

Implications of spillover effects within the family for medical cost-effectiveness analysis.

Anirban Basu1, David Meltzer.   

Abstract

Medical cost-effectiveness analyses traditionally treat patients as isolated individuals and neglect the effects of improvement in patients' health on the welfare of their family members. We use a model based on a family utility function with altruistic linkages to show that there can be direct and indirect effects on the welfare of all family members. We focus specially on a model of how the spillover effects to the spouse in a two-person family might affect choice of treatments for prostate cancer. We then test the predictions of this model by analyzing treatment choices of prostate cancer patients using the linked SEER-Medicare database. We find that our results are consistent with the model's predictions. We conclude that cost-effectiveness analyses may better reflect the full costs and benefits of medical interventions if they incorporate these family effects. However, concerns about equity present a dilemma for the practice of CEA from the societal perspective.

Entities:  

Mesh:

Year:  2005        PMID: 15960995     DOI: 10.1016/j.jhealeco.2004.12.002

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  49 in total

1.  Valuing children's health: whose quality of life matters?

Authors:  Eve Wittenberg
Journal:  Pharmacoeconomics       Date:  2012-08-01       Impact factor: 4.981

Review 2.  The humanistic and economic burden of juvenile idiopathic arthritis in the era of biologic medication.

Authors:  Wendy Gidman; Rachel Meacock; Deborah Symmons
Journal:  Curr Rheumatol Rep       Date:  2015-05       Impact factor: 4.592

3.  Carer preferences in economic evaluation and healthcare decision making.

Authors:  Hareth Al-Janabi; Nikki McCaffrey; Julie Ratcliffe
Journal:  Patient       Date:  2013       Impact factor: 3.883

4.  Measuring health and well-being effects in family caregivers of children with craniofacial malformations.

Authors:  Nalin Payakachat; J Mick Tilford; Werner Bf Brouwer; N Job van Exel; Scott D Grosse
Journal:  Qual Life Res       Date:  2011-02-24       Impact factor: 4.147

Review 5.  Does including informal care in economic evaluations matter? A systematic review of inclusion and impact of informal care in cost-effectiveness studies.

Authors:  Marieke Krol; Jocé Papenburg; Job van Exel
Journal:  Pharmacoeconomics       Date:  2015-02       Impact factor: 4.981

6.  Spillover Effects on Caregivers' and Family Members' Utility: A Systematic Review of the Literature.

Authors:  Eve Wittenberg; Lyndon P James; Lisa A Prosser
Journal:  Pharmacoeconomics       Date:  2019-04       Impact factor: 4.981

7.  Advances in Methods and Novel Applications for Measuring Family Spillover Effects of Illness.

Authors:  Lisa A Prosser; Eve Wittenberg
Journal:  Pharmacoeconomics       Date:  2019-04       Impact factor: 4.981

8.  Defining Value: The Need for a Longer, Broader View.

Authors:  Tomas J Philipson; Sachin Kamal-Bahl; Anupam B Jena
Journal:  Pharmacoeconomics       Date:  2017-07       Impact factor: 4.981

9.  The Monetary Value of Informal Care: Obtaining Pure Time Valuations Using a Discrete Choice Experiment.

Authors:  Renske J Hoefman; Job van Exel; Werner B F Brouwer
Journal:  Pharmacoeconomics       Date:  2019-04       Impact factor: 4.981

10.  Measuring benefits of opioid misuse treatment for economic evaluation: health-related quality of life of opioid-dependent individuals and their spouses as assessed by a sample of the US population.

Authors:  Eve Wittenberg; Jeremy W Bray; Brandon Aden; Achamyeleh Gebremariam; Bohdan Nosyk; Bruce R Schackman
Journal:  Addiction       Date:  2015-12-17       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.